Fifth Lane Capital »

Avadel Pharmaceuticals shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $521k 24k 21.55

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hologic Call Option (HOLX)
Renatus Tactical Acquis Shs Cl A (RTAC)
Avidity Biosciences Ord (RNA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cantor Equity Partners Iv Shs Cl A (CEPF)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Amazon Call Option (AMZN)
Cantor Equity Partners Ii Cl A Ord Shs (CEPT)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Futurecrest Acquisition Cl A Ord Shs (FCRS)
Btc Dev Corp Ord Shs Cl A (BDCI)
UnitedHealth (UNH)

View all positions for Fifth Lane Capital

Top funds holding Avadel Pharmaceuticals

Henderson Group
BlackRock
Jeffrey L. Gendell
Vanguard Group
Vivo Capital
State Street Corporation
Geode Capital Management
Highbridge Capital Management
Susquehanna International
Wealth Effects
Citadel Advisors
Kennedy Capital Management
Water Island Capital
Krensavage Asset Management
Northern Trust

View all funds holding Avadel Pharmaceuticals